![Yann Echelard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yann Echelard
Directeur/Membre du Conseil chez
TG THERAPEUTICS, INC.
Fortune : 12 M $ au 30/09/2026
Profil
Dr. Yann Echelard is a Managing Partner at ORI Capital Ltd., a President at Ampersand Biomedicines, Inc., an Operating Partner at Flagship Pioneering Inc and an Independent Director at TG Therapeutics, Inc. He is on the Board of Directors at TG Therapeutics, Inc., Hema Biologics and LFB USA, Inc. Dr. Echelard was previously employed as a President by Profound Therapeutics, Inc., a President, Chief Executive Officer & Director by rEVO Biologics, Inc., a Founding President by Cellarity Inc., a President by Laronde, Inc., and a President by Ring Therapeutics, Inc. He also served on the board at GTC Biotherapeutics UK Ltd. He received his doctorate degree from the University of Montréal.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TG THERAPEUTICS, INC. 0,15 % | 11/06/2026 | 223 816 ( 0,15 % ) | 12 M $ | 30/09/2026 |
Postes actifs de Yann Echelard
| Sociétés | Poste | Début |
|---|---|---|
| TG THERAPEUTICS, INC. | Directeur/Membre du Conseil | 09/11/2012 |
Hema Biologics
 Hema Biologics Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
LFB USA, Inc.
 LFB USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicinal products | Directeur/Membre du Conseil | - |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 01/10/2018 |
Ampersand Biomedicines
 Ampersand Biomedicines BiotechnologyHealth Technology Develops and manufactures medicines | Fondateur | 01/01/2021 |
ORI Capital Investment Advisory Hong Kong Ltd.
 ORI Capital Investment Advisory Hong Kong Ltd. Investment ManagersFinance ORI Capital invests in companies located across the globe. The firm targets companies operating in the fields of biotech with a focus on diagnostics, drug delivery, and therapeutics. It participates in early-stage transactions. | Private Equity Investor | 01/07/2026 |
Anciens postes connus de Yann Echelard
| Sociétés | Poste | Fin |
|---|---|---|
| REVO BIOLOGICS INC | Directeur Général | 01/04/2018 |
GTC Biotherapeutics UK Ltd. | Directeur/Membre du Conseil | 01/12/2010 |
Profound Therapeutics
 Profound Therapeutics Pharmaceuticals: OtherHealth Technology Develops human proteome therapeutics discovery services | Fondateur | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Yann Echelard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
University of Montréal
 University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions | Health Technology |
LFB USA, Inc.
LFB USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicinal products | Health Technology |
GTC Biotherapeutics UK Ltd. | |
ORI Capital Investment Advisory Hong Kong Ltd.
ORI Capital Investment Advisory Hong Kong Ltd. Investment ManagersFinance ORI Capital invests in companies located across the globe. The firm targets companies operating in the fields of biotech with a focus on diagnostics, drug delivery, and therapeutics. It participates in early-stage transactions. | Finance |
Hema Biologics
Hema Biologics Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Health Technology |
Cellarity Inc.
 Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Technology Services |
Laronde Inc.
 Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Develops an eRNA therapeutic platform that capable diverse proteins inside body | Commercial Services |
Profound Therapeutics
Profound Therapeutics Pharmaceuticals: OtherHealth Technology Develops human proteome therapeutics discovery services | Health Technology |
Ampersand Biomedicines
Ampersand Biomedicines BiotechnologyHealth Technology Develops and manufactures medicines | Health Technology |
